What daily oral dose of niacinamide should be given to a patient without liver disease, renal impairment, or allergy to the drug?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 21, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Recommended Daily Oral Dose of Niacinamide

For a patient without liver disease, renal impairment, or allergy, the recommended daily oral dose of niacinamide is 14-16 mg/day for maintenance (16 mg/day for males, 14 mg/day for females), with an upper safe limit of approximately 900 mg/day for adults. 1

Dosing Framework

Standard Maintenance Dosing

The 2022 ESPEN micronutrient guidelines establish clear dietary reference intakes (DRI) for niacin/nicotinamide based on age and sex 1:

  • Males >14 years: 16 mg/day
  • Females >14 years: 14 mg/day
  • Pregnant women: 18 mg/day
  • Lactating women: 16 mg/day

These doses represent the baseline nutritional requirement for healthy individuals without deficiency.

Upper Safety Limits

The critical distinction is between nicotinic acid and nicotinamide, as they have different safety profiles 1:

  • Nicotinamide (niacinamide): Upper limit is 12.5 mg/kg body weight/day, which equals approximately 900 mg/day for adults. This form does NOT cause flushing and has been studied at doses up to 25 mg/kg/day in diabetic patients without adverse effects 1.

  • Nicotinic acid: Upper limit is only 10 mg/day due to flushing and potential hypotensive episodes, particularly in elderly patients 1.

Clinical Context and Dose Escalation

When Higher Doses May Be Considered

While the question specifies a patient without deficiency or disease, research demonstrates that nicotinamide has been safely used at higher therapeutic doses in specific clinical contexts:

  • 500-1000 mg/day: Used in hemodialysis patients for phosphate control, though this caused thrombocytopenia at these doses 2
  • 80 mg/kg/day: Tolerated in cancer patients receiving radiotherapy (approximately 5600 mg for a 70 kg patient), though this is far beyond routine supplementation 3

Important Safety Considerations

Adverse effects are dose-dependent 4:

  • Below 1500 mg/day: Regular clinical monitoring may not be indicated
  • Common side effects at higher doses include GI upset, liver dysfunction, skin rash, and fatigue
  • Nicotinamide causes fewer adverse effects than nicotinic acid at equivalent doses 1, 4

Recent evidence on thrombocytopenia: A 2011 study found that nicotinamide at 500-1000 mg/day decreased platelet counts in hemodialysis patients 2, suggesting caution with prolonged use at doses exceeding the 900 mg/day upper limit.

Practical Dosing Algorithm

For your patient without contraindications:

  1. For general supplementation: Use 14-16 mg/day (standard DRI)
  2. For suspected subclinical deficiency: Can safely increase up to 900 mg/day
  3. Stay well below 900 mg/day for chronic daily use to avoid dose-dependent adverse effects
  4. Monitor for adverse effects if using doses >100 mg/day chronically, particularly GI symptoms, rash, or fatigue

The most conservative and evidence-based approach is to stay within the 14-16 mg/day range unless there is a specific clinical indication for higher doses, given that the upper limit of 900 mg/day represents a safety threshold rather than a therapeutic target 1.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.